AB
Adolore Biotherapeutics, Inc.
SEC filingBiotechnology · Delray Beach, FL
Amount raised$25Ksold at filing
Total offering$1M$975K still open
Investors in the raise1count reported to the SEC
FiledSep 29, 2025first sale Sep 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Paul Henry BaroneExecutive Officer, Director, Promoter
Mark Henry RogersDirector
Roelof Henry RongenExecutive Officer, Director
Roy Henry LevittExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.